NeurAxis Inc - Bathi resik saben saham (EPS TTM) NRXS

NeurAxis, Inc. (NRXS) specializes in pediatric neurostimulation via the IB-Stim device. However, the global chip shortage and trade barriers are hindering equipment deliveries, while physician training costs are slowing margin growth. In the GURU.Markets terminal, the annual percentage growth chart for EPS TTM visualizes profitability dynamics, with the current level of the indicator standing at -3.90.
Rincian metrik keuangan lan pasar NeurAxis, Inc. (NRXS)

For the innovative NeurAxis, Inc. (NRXS), with its focus on neuromodulation and commercialization risks, profit dynamics serve as a key indicator of the transition to the scaling stage. By analyzing historical year-over-year EPS growth (TTM), an investor assesses the rate of change in net income per share, which allows for a comparison of actual value generation against market expectations and determines the safety level of investments in this asset.